Description
Artesunate 60 mg Injection- Malaria can become life-threatening within minutes. At advanced stages, oral medications cannot always address the problem. The Artesunate 60 mg injection is a rapid-action antimalarial injection that is administered intravenously in a hospital to control severe/complicated malaria. It reduces the load of malaria parasites in the blood and minimizes the fatal complications. Doctors use this vital injection in hospitals all across India when time is precious.
This injection belongs to the artemisinin class of anti-malarial drugs. It is the WHO-recommended first-line treatment for severe malaria, preferred over quinine due to its better safety profile and faster parasite clearance.
F.C. Remedies manufactures this injection under the brand name FC-NATE. If pharma professionals are planning to enter the anti-malarial sector, then the Artesunate 60 mg injection PCD franchise business is a very good prospect. F.C. Remedies is providing PCD pharma franchise rights on a monopoly basis, and it is a safe business option for distributors dealing in Indian malaria regions.
Mechanism of Action of Artesunate Injection for Malaria
Artesunate acts by producing free radicals within the malaria parasite, which damage the parasite’s proteins and membranes, thereby destroying it internally. It is active against blood stages of the parasite, which are responsible for clinical symptoms. The quick action, therefore, leads to rapid clearance of parasites from the bloodstream. It is active against Plasmodium falciparum and even the resistant strains of it.
Indications
Artesunate 60 mg injection is used for the following:
- Severe and complicated Plasmodium falciparum malaria
- Malaria cases where oral treatment is not possible
- Multidrug-resistant malaria cases
- Cerebral malaria and malaria with organ complications
- High parasitemia cases requiring immediate parenteral treatment
- Malaria in patients who cannot tolerate oral anti-malarials
Why Artesunate Injection is Preferred in Severe Malaria
If malaria becomes complicated, doctors must be able to prescribe a rapid and dependable drug. The Artesunate 60 mg injection is just that. This drug is the first choice of physicians, recommended by the WHO, and effective even in the most complicated cases. As such, hospitals keep it in stock, and anti-malarial PCD franchise partners stock up on it as well.
- WHO recommendation – The World Health Organization now advocates for the use of artesunate injection instead of quinine for the management of severe malaria. This has allowed doctors worldwide to take this as their first-line treatment option with greater assurance.
- Faster parasitic clearance – Clearance of malarial parasites from the blood is much quicker in Artesunate injection compared to quinine. This feature is more relevant when the patient is fast deteriorating.
- Clinically more effective than Quinine- Artesunate has been shown to have improved survival rates in severe malaria as opposed to quinine. Quite simply, in the circumstances in which it is used, it is a better drug.
- Active against resistant strains- Where other anti-malarials fail, artesunate continues to work. The relevance of this is highlighted in areas of very high drug resistance.
- More favorable safety profile- Well tolerated compared to quinine, particularly by the children, the elderly, and pregnant women. Fewer side effects lead to a safer therapy.
- Life-saving in organ complications- In severe malaria with cerebral malaria or organ failure, this injection is involved in directly preventing death.
For PCD franchise distributors operating in malaria-prone states like Odisha, Jharkhand, Chhattisgarh, and Northeast India, this is a high-demand product. PCD pharma franchise partners in these regions see consistent orders, especially during peak malaria season.
How to Get the Artesunate Injection PCD Pharma Franchise
If you are looking for a pharma franchise product that actually moves, Artesunate injection is one worth considering seriously.
- High Demand Zone Product- Hospitals, PHCs, and district health centers in malaria-affected areas need this injection regularly, with demand peaking between June and November. This is not a product that sits on shelves.
- Government and Private Hospital Supply- Artesunate injection works well across both private distribution and government tender channels, giving franchise partners two solid revenue streams from a single product.
- Monopoly Rights Available- F.C. Remedies offers exclusive territory rights to its PCD franchise partners. That means once you claim your area, you operate without internal competition.
- WHO-GMP Certified Supply- Every batch is manufactured under WHO-GMP standards. This makes it significantly easier to meet government procurement requirements and build credibility with institutional buyers.
- Simple Onboarding- The process is straightforward, submit your drug license and GST certificate, select your preferred territory, and you are ready to go. No complicated paperwork, no long waiting periods.
Precautions for Fast-Acting Antimalarial Injection
While a fast-acting antimalarial injection is highly effective in treating severe malaria, certain precautions should be followed to ensure safe and successful treatment.
- Artesunate 60 mg injection must only be given under the direct supervision of a doctor in a hospital.
- Tell your doctor before treatment begins if the patient has been diagnosed as having kidney or liver disease.
- Should be used with caution in pregnancy. In the first trimester the risk of using the drug should be balanced with the benefit by the doctor.
- During treatment and after treatment the patient should be watched for the symptoms of low blood sugar, as hypoglycemia may develop.
- The injection should not be used for uncomplicated or mild cases of malaria but only for severe cases.
Although this injection is tolerable, healthcare professionals should consider specific precautions before and during its administration.
- Inform your doctor if you have known kidney or liver problems before starting treatment.
- Use this injection with caution in pregnant women, especially during the first trimester.
- Monitor the patient for signs of low blood sugar during and after treatment, as hypoglycemia can occur.
- Do not use this injection for mild or uncomplicated malaria cases; it is intended for severe malaria only.
